Longmen Capital is a private equity firm focused on investing in the medical sector.
Longmen Capital is a private equity firm focused on investing in the medical sector.The Shenzhen, Guangdong-headquartered firm was founded in 2017.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 10, 2022
Kaidi Medical
|
Series A | ¥100M | — | |
Jan 7, 2022
Crystal Egg Bio
|
Seed | — | Biopharma | Yes |
Dec 23, 2021
Qiyu Biotech
|
Series B | ¥200M | Biotechnology | — |
May 27, 2021
Hopstem
|
Series A | — | Biotechnology | — |
Mar 29, 2021
Chinagene Tech
|
Seed | ¥70M | Clinical Trials | — |